NCT05420948 2026-04-09
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
University of Chicago
Phase 2 Suspended
University of Chicago
M.D. Anderson Cancer Center
Emory University
Thomas Jefferson University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University